NCT05587491View on ClinicalTrials.gov

HybridAPC for Gastric Mucosal Ablation in Obese Patients.

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 27, 2023

Primary Completion Date

April 15, 2025

Study Completion Date

April 15, 2025

Conditions
ObesityAdiposity
Interventions
DEVICE

Hybrid Argonplasma coagulation (HAPC)

Gastric mucosal ablation is an endoscopic procedure which uses argonplasma coagulation in combination with submucosal injection to achieve selective ablation

Trial Locations (1)

2028

The Bariatric & Metabolic Institute The BMI Clinic, Double Bay

Sponsors
All Listed Sponsors
collaborator

ERBE AUSTRALIA PTY LTD

UNKNOWN

lead

Erbe Elektromedizin GmbH

INDUSTRY

NCT05587491 - HybridAPC for Gastric Mucosal Ablation in Obese Patients. | Biotech Hunter | Biotech Hunter